Bloomberg
Avantor Wants to Bring Vaccine to Market in Record Time: CEO
Nov.18 -- Avantor President and Chief Executive Officer Michael Stubblefield discusses the company's role in the fight against the Covid-19 pandemic with Bloomberg's Vonnie Quinn on "Bloomberg Markets."
Bloomberg
Alexandria Real Estate Chair: Light at End of Tunnel on Covid
Oct.28 -- Alexandria Real Estate Equities Inc. Chairman Joel Marcus says the company's tenants are doing amazing things on Covid-19 vaccine research. He speaks with Bloomberg's Vonnie Quinn on "Bloomberg Markets."
Bloomberg
PGIM CEO Hunt Says It's a Great Time to Be an Active Investor
Mar.26 -- PGIM CEO David Hunt sees investment opportunities in private credit and health sciences. He speaks with Bloomberg's David Westin on "Balance of Power."
Bloomberg
Biogen CEO Sees New Chapter in Fight Against Alzheimer's
Jun.07 -- Biogen CEO Michel Vounatsos discusses the implications of the FDA's approval of the company's controversial Alzheimer’s disease therapy, which will be sold under the name Aduhelm. He speaks on "Bloomberg Markets: The Close."
Bloomberg
'Real Tech' Built in Boston, Not Silicon Valley: Ginkgo Bioworks
May.11 -- Ginkgo Bioworks Inc's CEO Jason Kelly and Moderna Inc's co-founder and chairman Noubar Afeyan discuss the rise of biotech companies in Boston and how the city drives so much innovation. They speak to Emily Chang on "Bloomberg...
Bloomberg
SoftBank to Invest in Biotech Stocks
Feb.23 -- SoftBank Corp. is said to be opening a new front in its growing asset management strategy with plans to expand investment in biotech and healthcare. This provides more clues as to how founder Masayoshi Son plans to spend more...
Bloomberg
Covid Test Startup Color Health CEO on Series E Funding
Color Health CEO Othman Laraki joins Caroline Hyde to discuss the company's recent funding and how it will help expand its more than 6,500 Covid-19 testing sites in offices and schools; and to talk about what post-pandemic routine health...
Curated Video
Trial Begins For Theranos Founder Elizabeth Holmes
Holmes faces 12 wire-fraud related charges and up to 20 years in prison for duping investors in her "revolutionary" blood testing biotech startup.
Bloomberg
Covid Is Rallying Cry for Biotech, Genentech CEO Says
Genentech CEO Alexander Hardy says the Covid-19 pandemic has exposed the inequities in the health-care industry. He speaks on "Bloomberg Markets." (Source: Bloomberg)
Bloomberg
Which Vaccine Has the Highest Efficacy Against Delta?
Jul.19 -- Ben Cowling, professor of infectious disease epidemiology at the University of Hong Kong's School of Public Health who advises the government on the vaccination process, discusses vaccine efficacies. He also talks about his...
Bloomberg
Morningstar's Lee on China's Healthcare Outlook
Sep.01 -- Jay Lee, Equity Analyst at Morningstar discusses China's healthcare outlook. He speaks with Haidi Stroud-Watts and Kathleen Hays on "Bloomberg Daybreak: Asia".
Bloomberg
Investing in ESG and Renewables
Afsaneh Beschloss, RockCreek CEO and Greg Peters, PGIM Fixed Income Co-CIO talk about why the high yield market is different this cycle and why long duration is best heading into a recession.
Bloomberg
Nasdaq Biotech Index on Pace for Biggest Gain in 6 Weeks
Bloomberg's Abigail Doolittle takes a look at the performance of pharmaceutical stocks. She speaks on "Bloomberg Markets." (Source: Bloomberg)
Bloomberg
Verily's Breakthrough Biotech Goals
June 6 -- Jessica Mega, Verily Life Sciences chief medical officer, discusses the company's breakthrough biotech goals and life sciences funding with Bloomberg's Emily Chang on "Bloomberg West." David Kirkpatrick, Techonomy's chief...
Bloomberg
The Next Wave of Science: Will FDA Approve Cell Therapy?
July 11 -- Cell therapies -- where immune cells are removed from the body and engineered to hunt cancers -- may be available in the U.S. as soon as next year. They offer a potential one-time cure for deadly blood cancers that resist all...
Bloomberg
Trump Trade: Should You Buy the Biotech Dips?
Jan.12 -- Michael King, senior analyst at JMP Securities, examines the sharp decline in biotech stocks in response to criticism on drug pricing from President-elect Donald Trump. He speaks on "Bloomberg Daybreak: Americas."
Bloomberg
The Future of Aerospace Funding
Nov.29 -- Francois Chopard, Starburst Accelerator founder, discusses aerospace funding with Bloomberg's Emily Chang on "Bloomberg Technology."
Bloomberg
Alexandria Real Estate Equities CEO on Biotech Campuses
Oct.20 -- Joel Marcus, Alexandria Real Estate Equities chief executive officer, discusses developing medical campuses. He speaks with Bloomberg's Erik Schatzker at the Robin Hood Investors Conference in New York.
Bloomberg
Why the Divergence Between U.S. and Global Stocks Is Cause for Concern
Sep.12 -- David Keller, Sierra Alpha Research chief strategist, explains why he is concerned about the divergence between U.S. equities and the rest of the world. He speaks with Bloomberg's Abigail Doolittle on "Bloomberg Markets: What'd...
Bloomberg
China A-Shares Likely to Outperform, Atlantis Investment's Liu Says
Feb.10 -- Yang Liu, chief investment officer at Atlantis Investment Management Ltd., talks about Chinese stocks and her investment strategy. She speaks with Yvonne Man, Rishaad Salamat and David Ingles on "Bloomberg Markets: China Open."
Bloomberg
U.S. Health-Care, Tech Stocks Favored, Direxion Says
Jan.09 -- Sylvia Jablonski, managing director of capital markets at Direxion, talks about U.S. and Asian stocks. She speaks with Sophie Kamaruddin and Haidi Stroud-Watts on "Bloomberg Daybreak: Asia."
Bloomberg
Qiming Ventures Sees More U.S. Entrepreneurs in China
Nov.21 -- Nisa Leung, managing partner at Qiming Venture Partners, discusses healthcare innovation in China, biotech and her investment strategy. She speaks exclusively on “Bloomberg Markets: Asia” from the sidelines of Bloomberg's New...
Bloomberg
Dyadic Getting Ahead of the Curve on Coronavirus Cure, CEO Says
Jan.31 -- Mark Emalfarb, Dyadic International chief executive officer, discusses the efforts to find a vaccine for the deadly coronavirus. He speaks with Bloomberg's Taylor Riggs on "Bloomberg Technology."
Bloomberg
Defiance ETFs CIO on 2021 Market Expectation
Dec.23 -- Defiance ETFs CIO Sylvia Jablonski discusses the market expectation in 2021. She speaks with Shery Ahn and Paul Allen on "Bloomberg Daybreak: Asia."